Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
61 - 64 of 64 search results for `Research news` |u:mitocamb.medschl.cam.ac.uk

  1. Fully-matching results

  2. Development of a patient reported outcome measure (PROM) for patients …

    https://mitocamb.medschl.cam.ac.uk/our-research/research-studies/survey-studies/development-of-a-patient-reported-outcome-measure-prom-for-patients-with-inherited-optic-neuropathy-ion/
    23 Feb 2024: 👣 Unique Feet. 🧬 Rare Disease Research Network. 🪪 Rare passport. ... More: https://www.cambridge-symposium.org.uk. Really great get together at the @MRCMouseNetwork Science Day in York yesterday MitoCluster PI @CarloViscomi & ECR Pedro

  3. Understanding the progression over time of hereditary spastic…

    https://mitocamb.medschl.cam.ac.uk/our-research/research-studies/understanding-studies/understanding-the-progression-over-time-of-hereditary-spastic-paraplegia-hsp-ataxia-and-related-conditions-prospax/
    23 Feb 2024: This means that anonymised data and samples can be made available to other scientists for further studies upon request, to have as much impact as possible for research into HSP, ataxia ... Research aims:. • To investigate the genetic basis and clinical

  4. DefINe: A randomised, double-blind, placebo-controlled trial…

    https://mitocamb.medschl.cam.ac.uk/our-research/clinical-trials/define-a-randomised-double-blind-placebo-controlled-trial-examining-the-safety-and-efficacy-of-deferiprone-in-patients-with-neuroferritinopathy/
    23 Feb 2024: Research aims. The main aim of this study is to learn how well the oral study drug (deferiprone) works and how safe the study drug is compared with placebo. ... More: https://www.cambridge-symposium.org.uk. Really great get together at the

  5. OSPREY Study: A Phase I, Open-Label Study to Investigate Antisense…

    https://mitocamb.medschl.cam.ac.uk/our-research/clinical-trials/osprey-study-a-phase-i-open-label-study-to-investigate-antisense-oligonucleotide-stk-002-in-patients-with-adoa/
    23 Feb 2024: 👣 Unique Feet. 🧬 Rare Disease Research Network. 🪪 Rare passport. ... More: https://www.cambridge-symposium.org.uk. Really great get together at the @MRCMouseNetwork Science Day in York yesterday MitoCluster PI @CarloViscomi & ECR Pedro

Refine your results

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.